Endometrial Cancer Comprehensive Molecular Classifier Test Panel near me in Ranchi

The Endometrial Cancer Comprehensive Molecular Classifier Test Panel is an advanced diagnostic package designed to provide an in-depth molecular and immunohistochemical profile for accurate classification, prognosis, and personalized treatment planning in endometrial cancers. The package includes Mismatch Repair (MMR) protein analysis by immunohistochemistry (IHC) to detect MMR deficiency or microsatellite instability, which is critical for immunotherapy guidance and hereditary cancer risk assessment. It also incorporates POLE gene mutation testing (exons 9–14) to identify ultra-mutated tumors with distinct prognostic and therapeutic implications. In addition, a 50-gene cancer hotspot mutation Next Generation Sequencing (NGS) panel using DNA evaluates key genes associated with endometrial cancer, such as CTNNB1, PTEN, PIK3CA, KRAS, and TP53, that provide actionable insights for targeted therapy and risk stratification. Getting tested with the Endometrial Cancer Comprehensive Molecular Classifier Test Panel enables clinicians to make informed, evidence-based treatment decisions to ensure that patients receive the most effective and optimized care in the management of endometrial cancer.

Note: One representative block of the tumor is required. However, 1-4 representative blocks of tumors are acceptable.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.